FAQ

TMSB15A gene

Known as: thymosin beta 15a, TMSNB, TMSB15 
This gene plays a role in both actin binding and cytoskeletal remodeling.
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2012
01220042012

Related topics

Related topics

5 relations
Cytoskeletal ModelingLigand BindingTMSB15A wt AlleleThymosin Beta-15A, human

Broader (1)

Genes

Related mentions per year

Related mentions per year

1948-2018
19401960198020002020
TMSB15A gene
Ligand Binding
Cytoskeletal Modeling
Genes
Thymosin Beta-15A, human
TMSB15A wt Allele

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Thymosin beta 15A (TMSB15A) is a predictor of chemotherapy response in triple-negative breast cancer
Background:Biomarkers predictive of pathological complete response (pCR) to neoadjuvant chemotherapy (NACT) of breast cancer are… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1.
We recently identified an additional isoform of human thymosin beta 15 (also known as NB-thymosin beta, gene name TMSB15A… (More)
Is this relevant?
2007
2007
Identification of novel VHL targets that are associated with the development of renal cell carcinoma
von Hippel–Lindau (VHL) disease is a dominantly inherited family cancer syndrome characterized by the development of retinal and… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes.
Cervical cancer (CC) cells exhibit complex karyotypic alterations, which is consistent with deregulation of numerous critical… (More)
Is this relevant?
2004
2004
Molecular characterizations of derivatives of HCT116 colorectal cancer cells that are resistant to the chemotherapeutic agent 5-fluorouracil.
5-Fluorouracil (5-FU) is the chemotherapeutic drug of choice for the treatment of metastatic colorectal cancer, but resistance to… (More)
Is this relevant?